INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Hillsdale Investment Management Inc.'s Holding History (CIK: 0001368465)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 90 Value ($000) $6 Avg Close — Range —
Q1 2024
Shares 80 Value ($000) $6 Avg Close — Range —
Q4 2023
Shares 80 Value ($000) $6 Avg Close — Range —
Q3 2023
Shares 50,700 Value ($000) $2,641 Avg Close — Range —
Q2 2023
Shares 48,460 Value ($000) $3,068 Avg Close — Range —
Q1 2023
Shares 84,600 Value ($000) $4,581 Avg Close — Range —
Q4 2022
Shares 95,900 Value ($000) $5,075 Avg Close — Range —
Q3 2022
Shares 94,000 Value ($000) $4,374 Avg Close — Range —
Q2 2022
Shares 14,100 Value ($000) $805 Avg Close — Range —